Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis

Nuclear Medicine Communications

Volumn 32, Issue 12, 2011, Pages 1155-1161

  Kim, Keunyoung ^a   Kim, Seong Jang ^a,b   Kim, In Joo ^a,b   Kim, Bum Soo ^a   Pak, Kyoungjune ^a   Kim, Heeyoung ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

F 18 fluorodeoxyglucose; infectious spondylitis; positron emission tomography computed tomography; spleen

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; FEMALE; HUMAN; INFECTIOUS SPONDYLITIS; LIVER; MALE; MEDICAL RECORD REVIEW; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SPLEEN; SPLEEN FUNCTION; SPONDYLITIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SPLEEN; SPONDYLITIS; SUPPURATION; TUBERCULOSIS; YOUNG ADULT;

EID: 80455143678     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834bbdf1     Document Type: Article

References (21)

1. Lin M, Shon IH, Lin P. Positron emission tomography: current status and future challenges. Intern Med J 2010; 40:19-29.
2. Zasadny KR,Wahl RL. Standardized uptake values of normal tissues at PET with 2-(fluorine-18)-fluoro-2 deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847-850.
3. Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN. Role of attenuation correction for fluorine-18-fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 1999; 26:31-38.
4. Meier JM, Alavi A, Iruvuri S, Alzeair S, Parker R, Houseni M, et al. Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography. Semin Nucl Med 2007; 37:154-172.
5. Rini J, Manalili EY, Hoffman MA, Karayalcin G, Mehrotra B, Tomas MB, Palestro CJ. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin Nucl Med 2002; 27:572-577.
6. Kawai S, Ikeda E, Sugiyama M, Matsumoto J, Hiquchi T, Zhang H, et al. Enhancement of splenic glucose metabolism during acute malarial infection: correlation of findings of FDG-PET imaging with pathological changes in a primate model of severe human malaria. Am J Trop Med Hyg 2006; 74:353-360.
7. Naheel A, Yun M, Alavi A. F-18 FDG uptake in congestive splenomegaly. Clin Nucl Med 2002; 27:210.
8. Tomas MB, Tronco GG, Karayalcin G, Palestro CJ. FDG uptake in infectious mononucleosis. Clin Positron Imaging 2000; 3:176.
9. Lustberg MB, Aras O, Meisenberg BR. FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma. Eur J Haematol 2008; 81:154-156.
10. Sheehy N, Israel DA. Acute varicella infection mimics recurrent Hodgkin's disease on F-18 FDG PET/CT. Clin Nucl Med 2007; 32: 820-821.
11. Burrell SC, Fischman AJ. Myelofibrosis on F-18 FDG PET imaging. Clin Nucl Med 2005; 30:674.
12. Wong CL, Fulham MJ. Increased splenic FDG uptake on PET in betathalassemia. Clin Nucl Med 2004; 29:266-267.
13. Maruoka H, Koga T, Takeo M, Honda S, Yuge K, Fukuda T, Aizawa H. Increased splenic fluorodeoxyglucose uptake in a patient with granulomatous angitis. Intern Med 2007; 46:909-911.
14. Nam HY, Kim SJ, Kim IJ, Kim BS, Pak K, Kim K. The clinical implication and prediction of diffuse splenic FDG uptake during cancer surveillance. Clin Nucl Med 2010; 35:759-763.
15. Engwerda CR, Beattie L, Amnte FH. The importance of spleen in malaria. Trends Parasitol 2005; 21:75-80.
16. Zhuang H, Yu JQ, Alavi A. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 2005; 43:121-134.
17. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26:308-314.
18. Shreve PD, Anzai Y,Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. RadioGraphics 1999; 19:61-77.
19. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. RadioGraphics 2005; 25:1357-1368.
20. Kraal G. Cells in the marginal zone of the spleen. Int Rev Cytol 1992; 132:31-73.
21. De Porto AP, Lammers AJ, Bennink RJ, ten Berge IJ, Speelman P, Hoekstra JB. Assessment of splenic function. Eur J Clin Microbiol Infect Dis 2010; 29:1465-1473.